{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:12:07Z","timestamp":1769069527051,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,29]]},"DOI":"10.7759\/cureus.63487","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T04:48:20Z","timestamp":1719722900000},"source":"Crossref","is-referenced-by-count":3,"title":["Multiple Episodes of Cardiac Arrest Induced by Treatment With Ibogaine: A Case Report"],"prefix":"10.7759","author":[{"given":"David","family":"Mestre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco P","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1310218","article-title":"Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study","volume":"44","author":"Noller GE","year":"2018","unstructured":"Noller GE, Frampton CM, Yazar-Klosinski B. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. Am J Drug Alcohol Abuse. 2018, 44:37-46. 10.1080\/00952990.2017.1310218","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2016.1138226","article-title":"How toxic is ibogaine?","volume":"54","author":"Litjens RP","year":"2016","unstructured":"Litjens RP, Brunt TM. How toxic is ibogaine?. Clin Toxicol (Phila). 2016, 54:297-302. 10.3109\/15563650.2016.1138226","journal-title":"Clin Toxicol (Phila)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron LP","year":"2021","unstructured":"Cameron LP, Tombari RJ, Lu J, et al.. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature. 2021, 589:474-9. 10.1038\/s41586-020-3008-z","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2007.08.034","article-title":"The ibogaine medical subculture","volume":"115","author":"Alper KR","year":"2008","unstructured":"Alper KR, Lotsof HS, Kaplan CD. The ibogaine medical subculture. J Ethnopharmacol. 2008, 115:9-24. 10.1016\/j.jep.2007.08.034","journal-title":"J Ethnopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the treatment of substance dependence","volume":"6","author":"Brown TK","year":"2013","unstructured":"Brown TK. Ibogaine in the treatment of substance dependence. Curr Drug Abuse Rev. 2013, 6:3-16. 10.2174\/15672050113109990001","journal-title":"Curr Drug Abuse Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish R","year":"2010","unstructured":"Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ. 2010, 341:c5475. 10.1136\/bmj.c5475","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05211.x","article-title":"18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action","volume":"914","author":"Glick SD","year":"2000","unstructured":"Glick SD, Maisonneuve IM, Szumlinski KK. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. Ann N Y Acad Sci. 2000, 914:369-86. 10.1111\/j.1749-6632.2000.tb05211.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-016-9366-y","article-title":"Anti-addiction drug ibogaine prolongs the action potential in human induced pluripotent stem cell-derived cardiomyocytes","volume":"17","author":"Rubi L","year":"2017","unstructured":"Rubi L, Eckert D, Boehm S, Hilber K, Koenig X. Anti-addiction drug ibogaine prolongs the action potential in human induced pluripotent stem cell-derived cardiomyocytes. Cardiovasc Toxicol. 2017, 17:215-8. 10.1007\/s12012-016-9366-y","journal-title":"Cardiovasc Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.743138","article-title":"The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage","volume":"291","author":"Lamothe SM","year":"2016","unstructured":"Lamothe SM, Guo J, Li W, Yang T, Zhang S. The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage. J Biol Chem. 2016, 291:20387-401. 10.1074\/jbc.M116.743138","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/add.15448","article-title":"Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study","volume":"117","author":"Knuijver T","year":"2022","unstructured":"Knuijver T, Schellekens A, Belgers M, Donders R, van Oosteren T, Kramers K, Verkes R. Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study. Addiction. 2022, 117:118-28. 10.1111\/add.15448","journal-title":"Addiction"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern W","year":"2003","unstructured":"Redfern W, Carlsson L, Davis A, et al.. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003, 58:32-45. 10.1016\/S0008-6363(02)00846-5","journal-title":"Cardiovasc Res"},{"key":"ref12","article-title":"Life-threatening complications of ibogaine: three case reports","volume":"70","author":"Paling FP","year":"2012","unstructured":"Paling FP, Andrews LM, Valk GD, Blom HJ. Life-threatening complications of ibogaine: three case reports. Neth J Med. 2012, 70:422-4.","journal-title":"Neth J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2045125315626073","article-title":"Ibogaine-associated cardiac arrest and death: case report and review of the literature","volume":"6","author":"Meisner JA","year":"2016","unstructured":"Meisner JA, Wilcox SR, Richards JB. Ibogaine-associated cardiac arrest and death: case report and review of the literature. Ther Adv Psychopharmacol. 2016, 6:95-8. 10.1177\/2045125315626073","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.12061","article-title":"Cardiac arrest after ibogaine intoxication","volume":"34","author":"Steinberg C","year":"2018","unstructured":"Steinberg C, Deyell MW. Cardiac arrest after ibogaine intoxication. J Arrhythm. 2018, 34:455-7. 10.1002\/joa3.12061","journal-title":"J Arrhythm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/264670-multiple-episodes-of-cardiac-arrest-induced-by-treatment-with-ibogaine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T04:48:24Z","timestamp":1719722904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/264670-multiple-episodes-of-cardiac-arrest-induced-by-treatment-with-ibogaine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.63487","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}